Felimazole 2.5 mg Coated Tablets for Cats
Felimazole 2.5 mg Coated Tablets for Cats
Authorised
- Thiamazole
Product identification
Medicine name:
Felimazole 2.5 mg Coated Tablets for Cats
Felimazole Vet. 2,5 mg drasjerte tabletter, til katt
Active substance:
- Thiamazole
Target species:
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Thiamazole2.50milligram(s)1.00Tablet
Pharmaceutical form:
-
Coated tablet
Withdrawal period by route of administration:
-
Oral use
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH03BB02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Norway
Package description:
- Tablet container: White polypropylene tub with white low density polyethylene tamper evident lid containing 100 tablets.
- Blister: Transparent PVC/Aclar – aluminium blister. Blister strips contain 25 tablets. Each carton contains 4 blister strips.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Genera d.d.
Responsible authority:
- Norwegian Medical Products Agency
Authorisation number:
- 08-6201
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0505/002
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Czechia
-
Denmark
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Italy
-
Luxembourg
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 11/02/2022
Norwegian (PDF)
Published on: 26/01/2022
How useful was this page?: